<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">114</article-id><article-id pub-id-type="doi">10.25208/0042-4609-2015-91-1-122-128</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DRUG TREATMENT IN DERMATOVENEROLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ФАРМАКОТЕРАПИЯ В ДЕРМАТОВЕНЕРОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">T* reatment of vulgar and plantar warts</article-title><trans-title-group xml:lang="ru"><trans-title>Лечение вульгарных и подошвенных бородавок</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khlebnikova</surname><given-names>A. N.</given-names></name><name xml:lang="ru"><surname>Хлебникова</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alb9696@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Seleznyova</surname><given-names>Ye. V.</given-names></name><name xml:lang="ru"><surname>Селезнева</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alb9696@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dorokhina</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Дорохина</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alb9696@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Mytishchi Regional Dermatovenerology Dispensary</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Мытищинский кожно-венерологический диспансер»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-02-24" publication-format="electronic"><day>24</day><month>02</month><year>2015</year></pub-date><volume>91</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>122</fpage><lpage>128</lpage><history><date date-type="received" iso-8601-date="2017-08-24"><day>24</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Khlebnikova A.N., Seleznyova Y.V., Dorokhina O.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Хлебникова А.Н., Селезнева Е.В., Дорохина О.В.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Khlebnikova A.N., Seleznyova Y.V., Dorokhina O.V.</copyright-holder><copyright-holder xml:lang="ru">Хлебникова А.Н., Селезнева Е.В., Дорохина О.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/114">https://vestnikdv.ru/jour/article/view/114</self-uri><abstract xml:lang="en"><p>The article presents data on clinical forms of warts associated with different types of human papillomavirus. The authors analyze the following wart treatment methods: excision, chemical and immune. Based on literature sources, the authors assess the efficacy, advantages and disadvantages of well-known treatment methods. The authors describe their own experience of treating primary and recurrent vulgar and plantar warts with an up-to-date chemical destruction drug - Mardil Zinc Max, a solution containing a complex compound of 1.5% zinc 2-chloropropionate in 2-chloropropionic acid. The efficacy of treatment of vulgar warts was 100%, and that of plantar ones - 62.5%. Clinical recovery was observed both in case of primary and recurrent processes. The treatment had no adverse effects or complications and was characterized by a low injury rate, good tolerance and full tissue recovery without any cosmetic defects.</p></abstract><trans-abstract xml:lang="ru"><p>Приведены данные о клинических разновидностях бородавок, ассоциированных с различными видами вируса папилломы человека. Анализируются методы, применяемые для лечения бородавок: эксцизионные, химические, иммунные. На основе данных литературы рассматриваются эффективность, преимущества и недостатки известных методов терапии. Приводится собственный опыт лечения первичных и рецидивных вульгарных и подошвенных бородавок современным препаратом для химической деструкции Мардил Цинк Макс, представляющим собой раствор, содержащий комплексное соединение цинка 2-хлорпропионата 1,5% в 2-хлорпропионовой кислоте. Эффективность лечения вульгарных бородавок составила 100%, подошвенных - 62,5%, клиническое излечение наблюдали как при первичном, так и при рецидивном характере процесса. Лечение характеризовалось отсутствием побочных эффектов и осложнений, малой травматичностью, хорошей переносимостью, полным восстановлением тканей без косметических дефектов.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>бородавки вульгарные</kwd><kwd>бородавки подошвенные</kwd><kwd>терапия</kwd><kwd>аппликационный метод</kwd><kwd>хлорпропионовая кислота</kwd><kwd>цинк</kwd><kwd>vulgar warts</kwd><kwd>plantar warts</kwd><kwd>therapy</kwd><kwd>application method</kwd><kwd>chloropropionic acid</kwd><kwd>zinc</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Manykin А.А. Papillomavirusa. Medical virology under editions Lvova D.K. 2008. С. 269-276.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bellew S.G., Quartarolo N., Janniger C.K. Childhood warts: an update. Cutis 2004; 73 (6): 379-84.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Jablonska S., Majewski S., Obalek S., Orth G. Cutaneous warts. Clin. Dermatol 1997; 15 (3): 309-19.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Plunkett A., Merlin K., Gill D., Zuo Y., Jolley D., Marks R. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int. J. Dermatol 1999; 38 (12): 901-8.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Silverberg N.B. Human papillomavirus infections in children. Curr. Opin. Pediatr 2004; 16 (4): 402-9.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Delius H., Saegling B., Bergmann K., Shamanin V., de Villiers E.M. The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR. Virology 1998; 240 (2): 359-65.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324 (1): 17-27.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Holland T.T., Weber C.B., James W.D. Tender periungual nodules. Myrmecia (deep palmoplantar warts). Arch. Dermatol 1992; 128 (1): 105-8.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Cohen P.R., Hebert A.A., Adler-Storthz K. Focal epithelial hyperplasia. Heck disease. Pediatr Dermatol 1993; 10 (3): 245-51.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Molochkov A.V., Khlebnikova A.N., Kuncevich ZH.S. Epithelial tumors of a skin. M: Binom, 2012.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Molochkov A.V., Bagramova G.E., Gureeva M.A., Khlebnikova A.N., Kucherov V.A., Stovbun S.V., Safronov D.Yu. Immunotropic and antiviral therapy of cuteneous neoplasms associated with papillomavirus infection 2012; 2: 75-78.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Bourke J.F., Berth-Jones J., Hutchinson P.E. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br. J. Dermatol 1995; 132 (2): 433-6.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Glister H.M. Jr., Roenigk R.K. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J. Am. Acad. Dermatol 1995; 32 (3): 436-41.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hughes P.S., Hughes A.P. Absence of human papillomavirus DNA in the plume of erbium: YAG laser-treated warts. J. Am. Acad. Dermatol 1998; 38 (3): 426 -8.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sloan K., Haberman H., Lynde C.W. Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis. J. Cutan. Med. Surg 1998; 2 (3): 142 -5.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kwok C.S., Holland R., Gibbs S. Efficacy of topical treatments for cutaneous warts: a metaanalysis and pooled analysis of randomized controlled trials. Br. J. Dermatol 2011; 165 (2): 233-46</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Cockayne S., Hewitt C., Hicks K., Jayakody S., Kang’ombe A.R., Stamuli E., et al.; EVerT Team. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. Br. Med. J 2011; 342: d3271.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gibbs S., Harvey I., Sterling J., Stark R. Local treatments for cutaneous warts: systematic review. Br. Med. J 2002; 325 (7362): 461.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gladsjo J.A., Alio Saenz A.B., Bergman J., Krikorian G., Cunningham B.B. 5% 5-fluorouracil cream for treatment of verruca vulgaris in children. Pediat. Dermatol 2009; 26: 279 -285</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Sterling J.C., Handfield-Jones S., Hudson P.V. Guidelines for the management of cutaneous warts. Br. J. Dermatol 2001; 144: 4-11.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lewis T.G., Nydorf E.D. Intralesional bleomycin for warts: a review. J. Drugs Dermatol 2006; 5 (6): 499-504.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Allam J.P., Hagemann T., Bieber T., Novak N. Successful treatment of therapy-resistant plantar verrucae vulgares with systemic interferon-beta. J. Dermatol 2004; 31 (7): 582-3.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Aksakal A.B., Ozden M.G., Atahan C., Onder M. Successful treatment of verruca plantaris with a single sublesional injection of interferon-alpha2a. Cline. Exp. Dermatol 2009; 34 (1): 16-9</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bagramova G.E., Sedova T.G., Khlebnikova A.N. Russian magazine of skin and venereal diseases 2013; № 1: 23-26.</mixed-citation></ref></ref-list></back></article>
